MBOTMicrobot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an en…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates Microbot Medical (MBOT) delivered earnings and revenue surprises of 0.00% and -22.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
SStockStory | ||
 After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT) Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. | ||
 Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although... | ||
 Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock? XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization. | ||
 Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality? InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside. | ||
 Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1? DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins. | ||
 Microbot Medical Begins Full U.S. Launch of LIBERTY System MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth. | ||
Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical... | ||